Cargando…
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells
BACKGROUND: The metabolic reprogramming of mesenchymal stem/stromal cells (MSC) favoring glycolysis has recently emerged as a new approach to improve their immunotherapeutic abilities. This strategy is associated with greater lactate release, and interestingly, recent studies have proposed lactate a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659074/ https://www.ncbi.nlm.nih.gov/pubmed/37981698 http://dx.doi.org/10.1186/s13287-023-03549-4 |
_version_ | 1785148279514726400 |
---|---|
author | Pradenas, Carolina Luque-Campos, Noymar Oyarce, Karina Contreras-Lopez, Rafael Bustamante-Barrientos, Felipe A. Bustos, Andrés Galvez-Jiron, Felipe Araya, María Jesús Asencio, Catalina Lagos, Raúl Herrera-Luna, Yeimi Abba Moussa, Daouda Hill, Charlotte Nicole Lara-Barba, Eliana Altamirano, Claudia Ortloff, Alexander Hidalgo-Fadic, Yessia Vega-Letter, Ana María García-Robles, María de los Ángeles Djouad, Farida Luz-Crawford, Patricia Elizondo-Vega, Roberto |
author_facet | Pradenas, Carolina Luque-Campos, Noymar Oyarce, Karina Contreras-Lopez, Rafael Bustamante-Barrientos, Felipe A. Bustos, Andrés Galvez-Jiron, Felipe Araya, María Jesús Asencio, Catalina Lagos, Raúl Herrera-Luna, Yeimi Abba Moussa, Daouda Hill, Charlotte Nicole Lara-Barba, Eliana Altamirano, Claudia Ortloff, Alexander Hidalgo-Fadic, Yessia Vega-Letter, Ana María García-Robles, María de los Ángeles Djouad, Farida Luz-Crawford, Patricia Elizondo-Vega, Roberto |
author_sort | Pradenas, Carolina |
collection | PubMed |
description | BACKGROUND: The metabolic reprogramming of mesenchymal stem/stromal cells (MSC) favoring glycolysis has recently emerged as a new approach to improve their immunotherapeutic abilities. This strategy is associated with greater lactate release, and interestingly, recent studies have proposed lactate as a functional suppressive molecule, changing the old paradigm of lactate as a waste product. Therefore, we evaluated the role of lactate as an alternative mediator of MSC immunosuppressive properties and its contribution to the enhanced immunoregulatory activity of glycolytic MSCs. MATERIALS AND METHODS: Murine CD4(+) T cells from C57BL/6 male mice were differentiated into proinflammatory Th1 or Th17 cells and cultured with either L-lactate, MSCs pretreated or not with the glycolytic inductor, oligomycin, and MSCs pretreated or not with a chemical inhibitor of lactate dehydrogenase A (LDHA), galloflavin or LDH siRNA to prevent lactate production. Additionally, we validated our results using human umbilical cord-derived MSCs (UC-MSCs) in a murine model of delayed type 1 hypersensitivity (DTH). RESULTS: Our results showed that 50 mM of exogenous L-lactate inhibited the proliferation rate and phenotype of CD4(+) T cell-derived Th1 or Th17 by 40% and 60%, respectively. Moreover, the suppressive activity of both glycolytic and basal MSCs was impaired when LDH activity was reduced. Likewise, in the DTH inflammation model, lactate production was required for MSC anti-inflammatory activity. This lactate dependent-immunosuppressive mechanism was confirmed in UC-MSCs through the inhibition of LDH, which significantly decreased their capacity to control proliferation of activated CD4(+) and CD8(+) human T cells by 30%. CONCLUSION: These findings identify a new MSC immunosuppressive pathway that is independent of the classical suppressive mechanism and demonstrated that the enhanced suppressive and therapeutic abilities of glycolytic MSCs depend at least in part on lactate production. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03549-4. |
format | Online Article Text |
id | pubmed-10659074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106590742023-11-19 Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells Pradenas, Carolina Luque-Campos, Noymar Oyarce, Karina Contreras-Lopez, Rafael Bustamante-Barrientos, Felipe A. Bustos, Andrés Galvez-Jiron, Felipe Araya, María Jesús Asencio, Catalina Lagos, Raúl Herrera-Luna, Yeimi Abba Moussa, Daouda Hill, Charlotte Nicole Lara-Barba, Eliana Altamirano, Claudia Ortloff, Alexander Hidalgo-Fadic, Yessia Vega-Letter, Ana María García-Robles, María de los Ángeles Djouad, Farida Luz-Crawford, Patricia Elizondo-Vega, Roberto Stem Cell Res Ther Research BACKGROUND: The metabolic reprogramming of mesenchymal stem/stromal cells (MSC) favoring glycolysis has recently emerged as a new approach to improve their immunotherapeutic abilities. This strategy is associated with greater lactate release, and interestingly, recent studies have proposed lactate as a functional suppressive molecule, changing the old paradigm of lactate as a waste product. Therefore, we evaluated the role of lactate as an alternative mediator of MSC immunosuppressive properties and its contribution to the enhanced immunoregulatory activity of glycolytic MSCs. MATERIALS AND METHODS: Murine CD4(+) T cells from C57BL/6 male mice were differentiated into proinflammatory Th1 or Th17 cells and cultured with either L-lactate, MSCs pretreated or not with the glycolytic inductor, oligomycin, and MSCs pretreated or not with a chemical inhibitor of lactate dehydrogenase A (LDHA), galloflavin or LDH siRNA to prevent lactate production. Additionally, we validated our results using human umbilical cord-derived MSCs (UC-MSCs) in a murine model of delayed type 1 hypersensitivity (DTH). RESULTS: Our results showed that 50 mM of exogenous L-lactate inhibited the proliferation rate and phenotype of CD4(+) T cell-derived Th1 or Th17 by 40% and 60%, respectively. Moreover, the suppressive activity of both glycolytic and basal MSCs was impaired when LDH activity was reduced. Likewise, in the DTH inflammation model, lactate production was required for MSC anti-inflammatory activity. This lactate dependent-immunosuppressive mechanism was confirmed in UC-MSCs through the inhibition of LDH, which significantly decreased their capacity to control proliferation of activated CD4(+) and CD8(+) human T cells by 30%. CONCLUSION: These findings identify a new MSC immunosuppressive pathway that is independent of the classical suppressive mechanism and demonstrated that the enhanced suppressive and therapeutic abilities of glycolytic MSCs depend at least in part on lactate production. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03549-4. BioMed Central 2023-11-19 /pmc/articles/PMC10659074/ /pubmed/37981698 http://dx.doi.org/10.1186/s13287-023-03549-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Pradenas, Carolina Luque-Campos, Noymar Oyarce, Karina Contreras-Lopez, Rafael Bustamante-Barrientos, Felipe A. Bustos, Andrés Galvez-Jiron, Felipe Araya, María Jesús Asencio, Catalina Lagos, Raúl Herrera-Luna, Yeimi Abba Moussa, Daouda Hill, Charlotte Nicole Lara-Barba, Eliana Altamirano, Claudia Ortloff, Alexander Hidalgo-Fadic, Yessia Vega-Letter, Ana María García-Robles, María de los Ángeles Djouad, Farida Luz-Crawford, Patricia Elizondo-Vega, Roberto Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells |
title | Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells |
title_full | Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells |
title_fullStr | Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells |
title_full_unstemmed | Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells |
title_short | Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells |
title_sort | lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659074/ https://www.ncbi.nlm.nih.gov/pubmed/37981698 http://dx.doi.org/10.1186/s13287-023-03549-4 |
work_keys_str_mv | AT pradenascarolina lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT luquecamposnoymar lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT oyarcekarina lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT contreraslopezrafael lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT bustamantebarrientosfelipea lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT bustosandres lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT galvezjironfelipe lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT arayamariajesus lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT asenciocatalina lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT lagosraul lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT herreralunayeimi lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT abbamoussadaouda lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT hillcharlottenicole lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT larabarbaeliana lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT altamiranoclaudia lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT ortloffalexander lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT hidalgofadicyessia lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT vegaletteranamaria lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT garciaroblesmariadelosangeles lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT djouadfarida lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT luzcrawfordpatricia lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells AT elizondovegaroberto lactateanalternativepathwayfortheimmunosuppressivepropertiesofmesenchymalstemstromalcells |